Iodine-123 IBZM
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Iodine-123 IBZM, covering 2014-02-25 to 2014-02-25. Get the full timeline:
Most recent: Clinical Trial Update: Feasibility of 123I-IBZM Scintigraphy (a D2 Agonist) in Patients With Pheochromocytoma (PHEO) and/or Paraganglioma (PGL) : Study Pilot [NA]